Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity

Use of anthracyclines such as doxorubicin (DOX), for the treatment of cancer, is known to induce cardiotoxicity, begetting numerous evaluations of this adverse effect. This review emphasizes the mechanism of how consideration of DOX-induced cardiotoxicity is important for the development of cardiopr...

Full description

Bibliographic Details
Main Authors: Himani Kumari, Wan-Hong Huang, Michael W. Y. Chan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardiotoxicity
chemotherapy
epigenetics
cancer
doxorubicin
Online Access:https://www.frontiersin.org/article/10.3389/fcvm.2020.00056/full

Similar Items

Similar Items